CNBX Pharmaceuticals Dismisses Independent Auditor Elkana Amitai

What Happened CNBX Pharmaceuticals (CNBX) filed a Form 8-K reporting that it dismissed its independent registered public accounting firm, Elkana Amitai CPA, effective September 28, 2026. The filing was made under Item 4.01 (Changes in Registrant’s Certifying Accountant) and included related exhibits under Item 9.01.

Key Details

• Dismissal effective date: September 28, 2026.
• Former accounting firm: Elkana Amitai CPA was dismissed as CNBX’s independent registered public accounting firm.
• Filing sections/exhibits: The 8-K was filed under Item 4.01 and Item 9.01 and includes a letter from Elkana Amitai CPA and the cover page interactive data file (Inline XBRL).
• Reason not stated: The filing does not disclose a reason for the dismissal or name a successor auditor.

Why It Matters A change in independent auditors is material because it can affect the timing and completion of future financial reviews or audits. Investors should watch for a follow-up filing naming a new auditor and any disclosures about the reasons for the change, potential delays in financial reporting, or audit-related adjustments. Such filings can provide more clarity about CNBX’s financial reporting process and any near-term impact on filings or investor confidence.